A recent study found only half of all drug studies recorded in a large Web-based, federal registry, ClinicalTrials.gov had been published in a journal. Of these published trials, most were not in a timely manner, and many contained only selective information, leaving out such things as “adverse events” and “serious adverse events”. How does this affect well-informed decision making about patients’ health, and what needs to be done to fix this? Read more here. (Source: Medical Daily, 12/3/13).